← Eichor
Condition: Ascites Malignant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ascites Malignant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
Phase 1/Phase 2 · 1 location(s) · Qilu Hospital of Shandong University · NCT06759064A Phase I Study of SIM0388 in Participants With Malignant Ascites.
Phase 1 · 1 location(s) · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT07007988Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
Phase 1/Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07435701GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With
Phase 1/Phase 2 · 1 location(s) · Kyushu University · NCT05438459The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in th
Phase 2 · 3 location(s) · Sun Yat-sen University · NCT06433869Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug
Phase N/A · 1 location(s) · Liu Huang · NCT06413212Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT06016179QOL and Sarcopenia in Patients With Ascites
Phase N/A · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT05726747Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor N
Phase 1/Phase 2 · 1 location(s) · Dong sheng Zhang · NCT07397819NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors
EARLY_Phase 1 · 1 location(s) · Base Therapeutics (Shanghai) Co., Ltd. · NCT07561437Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites
Phase 1/Phase 2 · 1 location(s) · Asan Medical Center · NCT07149090A Clinical Study of GK02 in Malignant Ascites
EARLY_Phase 1 · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT07378436
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.